Congress moves to dismantle vaccine-injury protections, exposing makers to unlimited lawsuits
H.R. 4668 — End the Vaccine Carveout Act · Filed by Paul Gosar (R-AZ) · 30 cosponsors · Introduced Jul 23, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill eliminates the liability shield that currently protects vaccine manufacturers and administrators from lawsuits over vaccine injuries. It allows people to sue vaccine makers and administrators directly in court for damages, removes time limits on filing such lawsuits, and repeals key sections of the National Vaccine Injury Compensation Program (NVICP). It also excludes COVID-19 vaccines from emergency-use liability protections.
Why we flagged it
The bill's core function is to remove legal protections for vaccine manufacturers and dismantle the no-fault compensation system, shifting liability risk from a predictable federal program to unpredictable civil litigation. This is fundamentally a deregulatory measure that benefits manufacturers' litigation defense at the expense of vaccine supply stability and public health infrastructure.
- Exclusion of COVID-19 vaccines from emergency-use liability protections (Section 319F–3 amendment) is substantively unrelated to the core NVICP liability-shield repeal and appears designed to single out one vaccine class for special treatment.
What the text implies
- Removal of time limits on vaccine-injury lawsuits creates indefinite tail liability for manufacturers, potentially making vaccine production economically unviable and discouraging investment in new vaccine development.
- Dismantling the NVICP eliminates a no-fault compensation system that historically paid claims faster and more predictably than civil courts; injured parties may face longer litigation timelines and higher legal costs.
The full analysis lists 5 implications of this text.
Who stands to gain
litigation firms (class-action and personal-injury bar); tort reform opponents; anti-vaccine advocacy groups